MYH9 and cancer: miR-25-3p and miR-133a-3p shared genes involved in cancer-related pathways such as cyclin dependent kinase inhibitor 1A (CDKN1A), E1A binding protein p300 (EP300), Erb-b2 receptor tyrosine kinase 2 (ERBB2), myosin heavy chain 9 (MYH9), integrin subunit alpha V (ITGAV), phosphatase and tensin homolog (PTEN), heat shock protein 90 alpha family class a member 1 (HSP90AA), frizzled class receptor 6 (FZD6), among others (Table S6).